Exploring the therapeutic potential of Xiangsha Liujunzi Wan in Crohn's disease: from network pharmacology approach to experimental validation
LJZW has the characteristics of multi-component, multi-target, and multi-pathway treatment, which helps to improve the treatment of CD, protect the intestinal barrier, and exert the effect of anti-inflammatory therapy by inhibiting PI3K-AKT and MAPK signaling pathways.
Authors
- Yuxuan Peng (ORCID: https://orcid.org/0000-0002-8448-4991)
- Linlin Zheng (ORCID: https://orcid.org/0000-0002-8902-1056)
- Ziyun Wei
- Fu Liu (ORCID: https://orcid.org/0000-0002-7393-2963)
- Jieyu Liu (ORCID: https://orcid.org/0000-0001-8550-7676)
- Xiao Ni (ORCID: https://orcid.org/0000-0002-8159-9275)
- Jianing Shang
- Yunwei Li
Institutions
- First Hospital of China Medical University (CN)
- China Medical University (CN)
Publication Details
- Journal
- Journal of Ethnopharmacology
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1016/j.jep.2024.118863
- Citations
- 9
- Primary Topic
- Pharmacological Effects of Natural Compounds
- Type
- article
- Field-Weighted Citation Impact
- 4.20